(讨论）乙肝的病位真的在肝吗？

食医

你没有搞清疫苗的问题当然不能理解为什么健康人注射爱滋病疫苗而感染爱滋病，-----这不是我说的，而是世界卫生组织在发布爱滋病疫苗试验失败的时候说的------我看到的文章是给健康人注射爱滋病疫苗而感染了爱滋病，而不是给已感染者注射爱滋病疫苗，你转帖的文章犯了一个致命性错误，就是说爱滋病疫苗是给已感染者注射的，-------如果你明白西医，你应该明白给已感染者注射的疫苗叫治疗性疫苗，这是一个最基本的常识问题------而如果你知道疫苗的研制生产应用等过程，你就绝不会那么简单地理解疫苗了，你就会明白疫苗如果研制质量不过关，不仅不能预防，反而是直接让你生病。
尽管你不怀好意来到这个论坛，但我仍然不希望你或者你的家人因为注射了错误地疫苗而抱憾终生，就象美国的那些大兵，没有死在战场上却因为注射了所谓应该预防疾病的疫苗而丧失了健康，生不如死，甚至有的人真的死了，祝你好运！

whitecoat

我也怀疑食医看到的资料的可靠性，请举证吧。

ecat

The following is the a more detailed report about the AIDA vaccine in Thailand.
November 12, 2003 – VaxGen, Inc. announced preliminary results from its randomized, double-blind, placebo-controlled Phase III clinical trial in Thailand to evaluate AIDSVAX B/E, an investigational vaccine (rgp 120) for the prevention of HIV infection.
The vaccine candidate did not show efficacy for either the primary or secondary endpoints. The primary endpoint for the trial was the prevention of infection by HIV, the virus that causes AIDS. The secondary endpoints concerned whether vaccination slowed the progression of disease among those who received the vaccine but later became infected with HIV. The vaccine candidate appeared to be well tolerated with no serious adverse events related to the vaccine. The vaccine cannot cause HIV infection.
The trial was well conducted in accordance with international good clinical practices. Extensive education and risk-reduction counseling were provided during the trial. Data indicate that study volunteers reported marked reductions in behaviors, including sharing of needles, associated with HIV infection.

The trial results were analyzed by scientists from the Bangkok Vaccine Evaluation Group (BVEG), the U.S. Centers for Disease Control and Prevention (CDC), the Statistical Center for HIV/AIDS Research and Prevention (SCHARP) of the Fred Hutchinson Cancer Research Center, and VaxGen.
About the Phase III Clinical Trial of AIDSVAX B/E
The trial was designed to evaluate the safety and efficacy of AIDSVAX B/E, primarily against the blood-borne transmission of HIV subtype E and one strain of HIV subtype B. The study volunteers were 2,546 injecting drug users in Bangkok, Thailand. During the 36-month trial, a total of seven injections were administered at months 0, 1, 6, 12, 18, 24 and 30. The ratio of vaccine to placebo recipients was 1:1.
During the trial, 105 volunteers who received placebo became infected with HIV; 106 volunteers who received at least one injection of AIDSVAX B/E became infected. The annualized infection rate in placebo and vaccine recipients was 3.1%.
The trial was conducted at 17 clinical sites in the greater Bangkok Metropolitan Area. Trial volunteers received education and counseling every six months to avoid behavior that could lead to HIV infection and were advised to assume that they may have received a placebo or that the vaccine might be ineffective.

桂枝汤

下面引用由ecat在 2004/03/10 05:58pm 发表的内容：
The following is the a more detailed report about the AIDA vaccine in Thailand.
November 12, 2003 – VaxGen, Inc. announced preliminary results from its randomized, double-blind, placebo-controll　...

这才是一篇关于爱滋病疫苗的报告.具有权威性.

whitecoat

大家看了没有？
上述的文献证明
1。The vaccine candidate appeared to be well tolerated with no serious adverse events related to the vaccine. The vaccine cannot cause HIV infection.
疫苗可以很好的耐受，没有发生严重副作用，疫苗不会导致HIV感染。
2.During the trial, 105 volunteers who received placebo became infected with HIV; 106 volunteers who received at least one injection of AIDSVAX B/E became infected. The annualized infection rate in placebo and vaccine recipients was 3.1%.
疫苗没有作用，因为和安慰剂相比二者的发病率是一样的。

秦越人

During the trial, 105 volunteers who received placebo became infected with HIV; 106 volunteers who received at least one injection of AIDSVAX B/E became infected.
试验评估期间发现，有105个接受安慰剂的试验人员，感染了肝炎；至少一次接受爱滋病毒疫苗注射的106人感染了爱滋病毒。

caoxibai

[这个贴子最后由caoxibai在 2004/03/10 08:14pm 第 1 次编辑]

下面引用由ecat在 2004/03/10 05:58pm 发表的内容：
The vaccine candidate appeared to be well tolerated with no serious adverse events related to the vaccine. The vaccine cannot cause HIV infection.
　...

   请问，到底谁说得对呢？

秦越人

The vaccine candidate appeared to be well tolerated with no serious adverse events related to the vaccine. The vaccine cannot cause HIV infection.
疫苗候选人似乎以被告知疫苗的非常安全，不会产生对试验人员的伤害，和不会受到爱滋病毒感染。

whitecoat

[这个贴子最后由whitecoat在 2004/03/10 08:32pm 第 1 次编辑]

下面引用由秦越人在 2004/03/10 08:17pm 发表的内容：
The vaccine candidate appeared to be well tolerated with no serious adverse events related to the vaccine. The vaccine cannot cause HIV infection.
疫苗候选人似乎以被告知疫苗的非常安全，不会产生对　...

没有“似乎”，也没有“被告之”——是“表明，呈现为”的意思，可以不直接翻译。

疫苗受试者呈现出对疫苗的良好耐受，而且没有发生与疫苗有关的严重副作用。疫苗不会导致HIV感染。

whitecoat

[这个贴子最后由whitecoat在 2004/03/10 08:37pm 第 1 次编辑]

下面引用由秦越人在 2004/03/10 08:01pm 发表的内容：
During the trial, 105 volunteers who received placebo became infected with HIV; 106 volunteers who received at least one injection of AIDSVAX B/E became infected.
试验评估期间发现，有105个接　...

试验期间，有105名接受安慰剂治疗的志愿者感染了HIV；在接受了一次以上AIDSVAX B/E 注射的志愿者中，则有106名发生HIV感染。